Court Reaffirms Right of Myriad Genetics to Patent Genes
Friday, August 17, 2012 - 21:20
in Biology & Nature
The company may patent two genes linked to breast and ovarian cancer, but may not patent methods of “comparing” or “analyzing” DNA sequences.